Human PD-1 ectodomain complexed with Pembrolizumab Fab

Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab.

0.1 M sodium citrate pH 5.6, 19 mM n-Decyl-N,N-dimethylglycine, 20% isopropanol and 20% PEG 4000

Programmed cell death protein 1, Pembrolizumab Fab light chain, Pembrolizumab Fab heavy chain

human PD-1 Pembrolizumab Fab, IMMUNE SYSTEM